Skin Laboratory PCL (BKK:SKIN)

Skin Laboratory PCL Balance Sheet

Financials in millions THB. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	56.84	72.36	27.84	41.21	36.83	44.26
Short-Term Investments	5.74	5.41	1.94	8.34	1.14	0.54
Cash & Short-Term Investments	62.58	77.77	29.78	49.55	37.97	44.8
Cash Growth	62.97%	161.14%	-39.89%	30.50%	-15.25%	-15.81%
Accounts Receivable	10.86	16.52	26.9	26.82	32.34	23.56
Other Receivables	0.56	2.69	0.09	0.07	0.52	0.86
Receivables	11.42	19.21	26.99	26.88	32.85	25.3
Inventory	22.55	19.22	19.28	18.41	22.69	27.97
Other Current Assets	0.65	0.66	0.15	0.41	-	-
Total Current Assets	97.21	116.86	76.2	95.25	93.51	98.07
Property, Plant & Equipment	1.57	2.39	3.61	5.55	4.67	4.76
Other Intangible Assets	0.28	0.3	0.33	0.17	0.06	0.05
Long-Term Deferred Tax Assets	3.27	3.61	4.64	3.33	3.26	0.45
Other Long-Term Assets	0.37	0.37	0.37	0.52	0.17	0.07
Total Assets	102.7	123.53	85.15	104.81	101.67	103.4

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	5.54	8.28	9.57	11.15	16.36	14.5
Accrued Expenses	2.89	4.65	4.13	5.99	2.67	4.33
Current Portion of Leases	0.79	1.33	1.24	1.5	0.74	0.26
Current Income Taxes Payable	-	-	3.07	2.29	0.85	2.08
Other Current Liabilities	3.42	4.75	1.51	6.95	5.52	0.83
Total Current Liabilities	12.65	19.01	19.52	27.88	26.15	22
Long-Term Leases	-	0.12	1.45	2.95	2.79	2.41
Pension & Post-Retirement Benefits	3.56	3.21	2.5	1.92	1.12	0.8
Total Liabilities	16.21	22.34	23.46	32.74	30.06	25.21

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	72	72	50	1	1	1
Additional Paid-In Capital	28.17	28.17	-	-	-	-
Retained Earnings	-13.68	1.02	11.69	71.07	70.6	77.19
Shareholders' Equity	86.49	101.19	61.69	72.07	71.6	78.19
Total Liabilities & Equity	102.7	123.53	85.15	104.81	101.67	103.4

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	0.79	1.45	2.68	4.45	3.54	2.67
Net Cash (Debt)	61.79	76.33	27.1	45.09	34.43	42.13
Net Cash Growth	70.11%	181.68%	-39.91%	30.98%	-18.28%	-7.00%
Net Cash Per Share	0.46	0.68	0.63	22.55	17.21	21.06
Filing Date Shares Outstanding	144	144	100	2	2	2
Total Common Shares Outstanding	144	144	100	2	2	2
Working Capital	84.55	97.85	56.69	67.37	67.36	76.08
Book Value Per Share	0.60	0.70	0.62	36.04	35.80	39.10
Tangible Book Value	86.21	100.89	61.36	71.9	71.54	78.14
Tangible Book Value Per Share	0.60	0.70	0.61	35.95	35.77	39.07
Buildings	-	-	-	-	1.01	1.01
Machinery	-	2.36	1.88	2.31	-	0.9

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 12, 2026

Data Sources Report a data error